Business description
SKAN is a Swiss company and a global market and technological leader for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN’s core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. Furthermore, the company offers its customers process support, services, and consumables.
Management board & Supervisory board
| CEO |
| Thomas Huber |
| Management board |
| Burim Maraj, Philippe Jérôme, Dr. Sascha Pawel, Marina Häni, Martin E. Steegmüller, Thomas Zinn, Ralf Krämer, Maria Cuevas Otero, Cornelia Henny-Weiss |
| Supervisory board |
| Beat Lüthi, Cornelia Gehrig, Oliver Baumann, Thomas Huber, Gregor Plattner, Patrick Schär |
Company data
| Name: |
SKAN N |
| Address: |
Kreuzstrasse 5,4123 Allschwil |
| Phone: |
+41 61 485 44 44 |
| Fax: |
- |
| E-mail: |
info@skan.com
|
| Internet: |
https://skan.com/en/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12-31 |
| Free Float: |
44.12% |
| IPO date: |
2021-10-28 |
Investor relations
| Name: |
Thomas Balmer / Alexandre Müller |
| IR phone: |
+41 43 268 32 32 |
| IR Fax: |
- |
| IR e-mail: |
ir@skan.com
|
